Who are Global Burden of Disease (GBD)'s investors?

Global Burden of Disease (GBD)'s investors include LeapFrog Investments.

Where is Global Burden of Disease (GBD) headquartered?

Global Burden of Disease (GBD) is headquartered in Seattle, US.

Global Burden of Disease (GBD)

Seattle, US · 2 known investors

Find your way into Global Burden of Disease (GBD)

Each arrow is one introduction. Sign up to fill in the first one.

98 people can intro you to Christopher

Ask Cam Patterson to introduce you to Christopher J.L. Murray

You →Cam · together at Harvard Center for Population and Development Studies →Christopher

Your email: who you already know at Global Burden of Disease (GBD), and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Global Burden of Disease (GBD) team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

IHME is an independent research institute at the University of Washington School of Medicine that generates scientific evidence on global health outcomes, disease burden, and forecasting to inform policy and health system decisions. The organization develops health metrics, applies AI and statistical methods to health data analysis, and studies health system capacity, climate impacts on health, and health equity across populations worldwide.

Data & Infrastructure Digital Health Healthtech Impact & Social Good

Founders & leadership

Christopher J.L. Murray Professor; IHME Director; Chair, Department of Health Metrics SciencesPhysician and health economist who founded the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, where he serves as director and leads work on global health measurement, disease burden analysis, and health system performance evaluation.

Investors · 2

LeapFrog Investmentslisted by LeapFrog InvestmentsLondon

Also in the syndicate · 1

Gates Foundation

Frequently asked questions

What does Global Burden of Disease (GBD) do?: IHME is an independent research institute at the University of Washington School of Medicine that generates scientific evidence on global health outcomes, disease burden, and forecasting to inform policy and health system decisions. The organization develops health metrics, applies AI and statistical methods to health data analysis, and studies health system capacity, climate impacts on health, and health equity across populations worldwide.
Who are Global Burden of Disease (GBD)'s investors?: Global Burden of Disease (GBD)'s investors include LeapFrog Investments.
Where is Global Burden of Disease (GBD) headquartered?: Global Burden of Disease (GBD) is headquartered in Seattle, US.